Table 1 General characteristics of the included studies (one study included more than one study drug)
From: New clinical application prospects of artemisinin and its derivatives: a scoping review
| Â | Artemisinin | Artesunate | Dihydroartemisinin | Artemether | Total | % |
|---|---|---|---|---|---|---|
Drug purpose | ||||||
Parasite | 1 | 22 | 1 | 11 | 35 | 43.2 |
Tumor | 2 | 13 | 1 | 0 | 16 | 19.8 |
Virus | 1 | 4 | 2 | 4 | 11 | 13.6 |
Inflammatory disease | 1 | 9 | 0 | 2 | 12 | 14.8 |
Skin disease | 0 | 4 | 0 | 3 | 7 | 8.6 |
Year of publication | ||||||
Before 2000 | 0 | 9 | 0 | 2 | 11 | 13.8 |
In or after 2000 | 5 | 42 | 4 | 18 | 69 | 86.2 |